Sio Capital Management, LLC Puma Biotechnology, Inc. Transaction History

Sio Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $658,938 - $1.53 Million	-32,832 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $1.35 Million - $1.96 Million	32,832 New	32,832 $1.51 Million
Q1 2018 May 15, 2018	SELL	$59.7 - $99.25 $728,877 - $1.21 Million	-12,209 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$93.85 - $132.45 $1.41 Million - $1.99 Million	-15,012 Reduced 55.15%	12,209 $1.21 Million
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $1.96 Million - $3.26 Million	27,221	27,221 $3.26 Million

102

29M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $138M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.